ITPR1 has been shown to be expressed in a broad variety of tumours (partly ectopically), particularly in Hodgkin disease (HD) and malignant lymphoid and myeloid cell lines, but also lung cancer, melanoma, prostate cancer and many other tumour entities [18]. Here, ITPR1 is linked to lung carcinoma.